|
Volumn 334, Issue 20, 1996, Pages 1333-1335
|
Prevention of coronary heart disease with pravastatin [1]
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CHOLESTEROL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
HYPOCHOLESTEROLEMIC AGENT;
PLACEBO;
PRAVASTATIN;
CLINICAL TRIAL;
DRUG COST;
HEART INFARCTION;
HUMAN;
HYPERCHOLESTEROLEMIA;
ISCHEMIC HEART DISEASE;
LETTER;
MALE;
MORTALITY;
PRIORITY JOURNAL;
CORONARY ARTERY DISEASE;
NOTE;
SURVIVAL;
ECONOMICS;
FEMALE;
ANTICHOLESTEREMIC AGENTS;
CORONARY DISEASE;
HUMANS;
HYPERCHOLESTEROLEMIA;
MALE;
PRAVASTATIN;
SURVIVAL ANALYSIS;
DRUG COSTS;
FEMALE;
|
EID: 0029913096
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM199605163342013 Document Type: Letter |
Times cited : (6)
|
References (0)
|